Literature DB >> 29200695

Metaplastic Carcinoma of Breast and Neurofibromatosis 1: A Rare Association.

Gnanapriya Vellaisamy1, Suravi Mohanty1, Pritilata Rout1, Suraj Manjunath2.   

Abstract

Neurofibromatosis 1 (NF1) patients are generally at higher risk of developing common malignant tumors such as brain and soft tissue tumors. These patients are 5-fold increased the risk of developing breast cancer by the age of 50 years after that the risk remains the same. The most common reported cancer is infiltrating duct carcinoma. We report a case of 61-year-old female with NF1 presented with pain and breast lump for the past 2 months. On mammography, a retroareolar solid cystic lesion measuring 32 mm × 30 mm × 30 mm was noted which was definitive for malignancy. Right-modified radical mastectomy with axillary lymph node dissection was done which revealed a neoplasm composed of glandular and squamous components. Immunohistochemically, these cells were triple negative for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-neu and expressed markers of basal cell differentiation. The final pathological staging was T2N0M0. This is the fourth case report in the English literature with such association. In this case report, we discussed the importance of breast cancer screening in such patients along with a review of the literature.

Entities:  

Keywords:  Breast screening; metaplastic; neurofibromatosis

Year:  2017        PMID: 29200695      PMCID: PMC5686988          DOI: 10.4103/ijmpo.ijmpo_7_17

Source DB:  PubMed          Journal:  Indian J Med Paediatr Oncol        ISSN: 0971-5851


  10 in total

1.  Increased risk of breast cancer in women with NF1.

Authors:  Sara Aileen Madanikia; Amanda Bergner; Xiaobu Ye; Jaishri O'Neill Blakeley
Journal:  Am J Med Genet A       Date:  2012-11-19       Impact factor: 2.802

2.  A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer.

Authors:  Sefik Güran; Mükerrem Safali
Journal:  Cancer Genet Cytogenet       Date:  2005-01-01

3.  Metaplastic breast cancer in a patient with neurofibromatosis.

Authors:  Umar Shafique Chaudhry; Limin Yang; Ryan W Askeland; Laurie L Fajardo
Journal:  J Clin Imaging Sci       Date:  2015-03-27

4.  Metaplastic carcinoma of the breast: multimodality imaging and histopathologic assessment.

Authors:  Bo Bae Choi; Kwang Sun Shu
Journal:  Acta Radiol       Date:  2011-11-16       Impact factor: 1.990

5.  Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.

Authors:  D G Evans; E Howard; C Giblin; T Clancy; H Spencer; S M Huson; F Lalloo
Journal:  Am J Med Genet A       Date:  2010-02       Impact factor: 2.802

6.  Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening.

Authors:  S Sharif; A Moran; S M Huson; R Iddenden; A Shenton; E Howard; D G R Evans
Journal:  J Med Genet       Date:  2007-03-16       Impact factor: 6.318

7.  Metaplastic breast carcinoma in a patient with Von Recklinghausen's disease.

Authors:  Ioannis Natsiopoulos; Aristides Chatzichristou; Ioannis Stratis; Anna Skordalaki; Nikolaos Makrantonakis
Journal:  Clin Breast Cancer       Date:  2007-04       Impact factor: 3.225

Review 8.  Current progress in the treatment of metaplastic breast carcinoma.

Authors:  Qing Hu; Wei-Xian Chen; Shan-Liang Zhong; Jian Li; Zhou Luo; Jin-Hai Tang; Jian-Hua Zhao
Journal:  Asian Pac J Cancer Prev       Date:  2013

9.  A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

Authors:  L Walker; D Thompson; D Easton; B Ponder; M Ponder; I Frayling; D Baralle
Journal:  Br J Cancer       Date:  2006-06-20       Impact factor: 7.640

10.  Oral metastasis of metaplastic breast carcinoma in a patient with neurofibromatosis 1.

Authors:  Ana Paula Molina Vivas; Luana Eschholz Bomfin; Clovis Antonio Lopes Pinto; Ulisses Ribaldo Nicolau; Fabio Abreu Alves
Journal:  Case Rep Oncol Med       Date:  2014-04-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.